Autor: |
Mark LaRocco, Susan M. Novak, Elizabeth M. Marlowe |
Rok vydání: |
2015 |
Předmět: |
|
Zdroj: |
Clinical Microbiology Newsletter. 37:17-21 |
ISSN: |
0196-4399 |
DOI: |
10.1016/j.clinmicnews.2015.01.004 |
Popis: |
In today's health care environment, laboratories are increasingly being asked to justify the acquisition of new technology. Justification is often done through a formal business case analysis. One important component of the business case is being able to show outcomes and impacts on patient care. Patient outcomes are becoming a focus of investigation following implementation of new technology and a key component to building a strong business case for that technology. Given that new technology is often more expensive than an add-on test to traditional work-ups, its true value is not fully appreciated unless it is evaluated over the continuum of care. This article discusses how to prepare a business case for the administration and key strategic considerations to create a value-driven laboratory. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|